Booth Mark D
Insider CIK 1470885 · OREX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2015-02-26 | 2015-03-02 | 50,000 | — | $0 | 563,924 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2015-02-26 | 2015-03-02 | 50,000 | $5.68 | $284.0K | 3,810 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2015-02-26 | 2015-03-02 | 50,000 | $1.66 | $83.0K | 53,810 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2015-02-03 | 2015-02-05 | 88,925 | — | $0 | 88,925 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2014-05-30 | 2015-02-05 | 4,218 | $5.25 | $22.1K | 8,028 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2014-02-07 | 2014-02-11 | 205,000 | — | $0 | 205,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award | 2013-11-29 | 2014-02-11 | 3,810 | $5.34 | $20.3K | 3,810 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-07-26 | 2013-07-29 | 64,767 | — | $0 | 613,924 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-07-26 | 2013-07-29 | 20,000 | $7.50 | $150.0K | 29,045 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-07-26 | 2013-07-29 | 64,767 | $1.66 | $107.5K | 64,767 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-07-26 | 2013-07-29 | 15,722 | $7.25 | $114.0K | 49,045 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-07-26 | 2013-07-29 | 29,045 | $7.75 | $225.1K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-03-11 | 2013-03-12 | 27,685 | — | $0 | 678,691 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-03-11 | 2013-03-12 | 27,685 | $1.66 | $46.0K | 27,685 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-03-11 | 2013-03-12 | 27,685 | $6.67 | $184.7K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2013-02-15 | 2013-02-19 | 190,000 | — | $0 | 190,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2013-01-15 | 2013-01-18 | 22,315 | — | $0 | 706,376 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-01-15 | 2013-01-18 | 100 | $6.68 | $668 | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2013-01-15 | 2013-01-18 | 22,215 | $6.67 | $148.2K | 100 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2013-01-15 | 2013-01-18 | 22,315 | $1.66 | $37.0K | 22,315 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise deriv | 2012-06-28 | 2012-06-29 | 103,309 | — | $0 | 728,691 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | S Sale | 2012-06-28 | 2012-06-29 | 103,309 | $5.66 | $584.7K | 0 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | M Exercise | 2012-06-28 | 2012-06-29 | 103,309 | $1.66 | $171.5K | 103,309 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-02-27 | 2012-02-28 | 70,000 | — | $0 | 70,000 | SEC↗ |
| OREX Orexigen Therapeutics, Inc | A Award deriv | 2012-01-25 | 2012-01-26 | 280,000 | — | $0 | 280,000 | SEC↗ |